Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Am Soc Nephrol ; 26(9): 2267-76, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-25745027

RESUMO

Lipid abnormalities may have an effect on clinical outcomes of patients on dialysis. Recent studies have indicated that HDL dysfunction is a hallmark of ESRD. In this study, we compared HDL composition and metrics of HDL functionality in patients undergoing hemodialysis (HD) or peritoneal dialysis (PD) with those in healthy controls. We detected a marked suppression of several metrics of HDL functionality in patients on HD or PD. Compositional analysis revealed that HDL from both dialysis groups shifted toward a more proinflammatory phenotype with profound alterations in the lipid moiety and protein composition. With regard to function, cholesterol efflux and anti-inflammatory and antiapoptotic functions seemed to be more severely suppressed in patients on HD, whereas HDL-associated paraoxonase activity was lowest in patients on PD. Quantification of enzyme activities involved in HDL metabolism suggested that HDL particle maturation and remodeling are altered in patients on HD or PD. In summary, our study provides mechanistic insights into the formation of dysfunctional HDL in patients with ESRD who are on HD or PD.


Assuntos
Falência Renal Crônica/sangue , Falência Renal Crônica/terapia , Lipoproteínas HDL/sangue , Lipoproteínas HDL/química , Diálise Renal/métodos , 1-Alquil-2-acetilglicerofosfocolina Esterase/metabolismo , Idoso , Arildialquilfosfatase/metabolismo , Estudos de Casos e Controles , Células Cultivadas , Colesterol/metabolismo , Proteínas de Transferência de Ésteres de Colesterol/sangue , Feminino , Humanos , Falência Renal Crônica/enzimologia , Lipopolissacarídeos/farmacologia , Lipase Lipoproteica/sangue , Lipoproteínas HDL/farmacologia , Macrófagos/metabolismo , Masculino , Pessoa de Meia-Idade , Monócitos/efeitos dos fármacos , Monócitos/metabolismo , NF-kappa B/metabolismo , Diálise Peritoneal , Fosfatidilcolina-Esterol O-Aciltransferase/sangue , Proteínas de Transferência de Fosfolipídeos/sangue , Triglicerídeos/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA